Would you consider allogeneic stem cell transplant for a newly diagnosed patient with favorable risk AML who had residual disease after initial therapy that included the need for re-induction?
Answer from: at Community Practice
Even though he/she is favorable risk, the fact that he/she required reinduction means biologically aggressive disease and hence increased risk of relapse. So would consider for allo sct.
Also was the induction 7+3 or HIDAC induction?
Did the patient go into CR after reinduction?
What did the NGS ...
Sign in or Register to read more